Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-02-14

Clinical Trial Update: Management of Human Immunodeficiency Virus 1 (HIV-1) Participants Treated With Antiretroviral (ARV) Combination Therapy Including Raltegravir (MK-0518-138)

View source ↗

Summary

A clinical trial update on HIV-1 participants treated with antiretroviral therapy that included raltegravir (MK-0518-138); the trial is completed and results we…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Isentress (Raltegravir)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: HIV Infections | Status: COMPLETED | Results posted: 2014-02-14